Concepedia

María del Mar Noblejas‐López

MD

Statistics

Publications

14

Citations

549

H-Index

13

Active since

2018

Affiliations

Centro de Investigación Biomédica en Red de Cáncer(Current)

University of Castilla-La Mancha

Instituto de Investigación Biomédica de Salamanca

Centro de Investigación del Cáncer

Hospital General Universitario de Albacete

María del Mar Noblejas‐López is an author at Centro de Investigación Biomédica en Red de Cáncer specializing in radiation oncology, breast cancer, and medicine.

ORCID

Top concepts

Publications per year

2018–2022

14

Publications

14

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, Miguel Burgos et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 93 citations · Full text

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, Sara Morcillo García et al. · OncoImmunology · 2019 · 79 citations · Full text

, , +21

Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer

Francisco J. Cimas, Enrique Niza, Alberto Juan et al. · Pharmaceutics · 2020 · 78 citations · Full text

, , +18

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

Enrique Niza, María del Mar Noblejas‐López, Iván Bravo et al. · Nanomaterials · 2019 · 57 citations · Full text

, , +17

Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy

Enrique Niza, Cristina Nieto‐Jiménez, María del Mar Noblejas‐López et al. · Nanomaterials · 2019 · 51 citations · Full text

, , +15

1–5 of 14